BRUNO, ANTONINO

BRUNO, ANTONINO  

DIPARTIMENTO DI BIOTECNOLOGIE E SCIENZE DELLA VITA  

Mostra records
Risultati 1 - 20 di 121 (tempo di esecuzione: 0.103 secondi).
Titolo Data di pubblicazione Autore(i) File
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity 1-gen-2021 Albini, A.; Festa, M. M. G.; Ring, N.; Baci, D.; Rehman, M.; Finzi, G.; Sessa, F.; Zacchigna, S.; Bruno, A.; Noonan, D. M.
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease 1-gen-2023 Gallo, Daniela; DE VITO, Annarosaria; Roncoroni, Rossella; Bruno, Antonino; Piantanida, ELIANA ANGELA ROSA; Bartalena, Luigi; Tanda, MARIA LAURA PIERA; Mortara, Lorenzo; Acquati, Francesco
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification 1-gen-2015 Fania, C; Sogno, I; Vasso, M; Torretta, E; Leone, R; Bruno, A; Consonni, P; Albini, A; Gelfi, C.
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 1-gen-2014 Bruno, A.; Ferlazzo, G.; Albini, A.; Noonan, D.
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies 1-gen-2019 Baci, D.; Bruno, A.; Cascini, C.; Gallazzi, M.; Mortara, L.; Sessa, F.; Pelosi, G.; Albini, A.; Noonan, D. M.
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways 1-gen-2018 Baci, D.; Bruno, A.; Bassani, B.; Tramacere, M.; Mortara, L.; Albini, A.; Noonan, D. M.
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 1-gen-2022 Gallo, Daniela; Mortara, Lorenzo; Veronesi, Giovanni; Cattaneo, Simona AM; Genoni, Angelo; Gallazzi, Matteo; Peruzzo, Carlo; Lasalvia, Paolo; Moretto, Paola; Bruno, Antonino; Passi, Alberto; Pini, Andrea; Nauti, Andrea; Lavizzari, Maria Antonietta; Marinò, Michele; Lanzolla, Giulia; Tanda, Maria Laura; Bartalena, Luigi; Piantanida, Eliana
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis 1-gen-2023 Barone, Ludovica; Palano, Maria Teresa; Gallazzi, Matteo; Cucchiara, Martina; Rossi, Federica; Borgese, Marina; Raspanti, Mario; Zecca, Piero Antonio; Mortara, Lorenzo; Papait, Roberto; Bernardini, Giovanni; Valdatta, Luigi; Bruno, Antonino; Gornati, Rosalba
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity 1-gen-2022 Benedetto, Nadia; Calabrone, Luana; Gutmańska, Karolina; Macrì, Nicoletta; Cerrito, Maria Grazia; Ricotta, Riccardo; Pelosi, Giuseppe; Bruno, Antonino; Noonan, Douglas M; Albini, Adriana
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 1-gen-2018 Bruno, A.; Bassani, B.; D’Urso, D. G.; Pitaku, Ilvana; Cassinotti, E.; Pelosi, Giuliano; Boni, L.; Dominioni, L.; Noonan, D. M.; Mortara, L.; Albini, A.
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy 1-gen-2018 Mortara, L.; Balza, E.; Bruno, A.; Poggi, A.; Orecchia, P.; Carnemolla, B.
Biomarkers of cancer angioprevention for clinical studies 1-gen-2015 Albini, Adriana; Bertolini, Francesco; Bassani, Barbara; Bruno, Antonino; Gallo, Cristina; Caraffi, Stefano Giuseppe; Maramotti, Sally; Noonan, Douglas
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity 1-gen-2015 Albini, Adriana; Bruno, Antonino; Gallo, Cristina; Pajardi, Giorgio; Noonan, Douglas; Dallaglio, Katiuscia
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection 1-gen-2020 Festa, M.; Sansone, C.; Brunet, C.; Crocetta, F.; Di Paola, L.; Lombardo, M.; Bruno, A.; Noonan, D. M.; Albini, A.
Characterization of circulating and tumor infiltrating Natural Killer cells in patients with pancreatic ductal adenocarcinoma: polarization state and effects of TGFβRI blockade 1-gen-2022 Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 1-gen-2023 Cucchiara, Martina; Gallazzi, Matteo; Coco, Grace; Bombelli, RAFFAELLA MARIA; Olmeo, Francesca; Franzi, Francesca; Famoso, Graziana; Sessa, Fausto; Capogrosso, Paolo; Dehò, Federico; Bruno, Antonino; Mortara, Lorenzo
Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments 1-gen-2022 Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Mortara, Lorenzo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino
Circulating Natural Killer cells in patients with symptomatic atherosclerosis acquire the CD9 + CD49a pro-inflammatory phenotype and support M1-like macrophage polarization 1-gen-2022 Cucchiara, Martina; Gallazzi, Matteo; Carlini, Valentina; Martelli, Massimiliano; Albini, Adriana; Bruno, Antonino; Noonan, Douglas
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 1-gen-2022 Scagliotti, Arianna; Capizzi, Laura; Cazzaniga, Marina Elena; Ilari, Alice; De Giorgi, Marco; Cordani, Nicoletta; Gallazzi, Matteo; Bruno, Antonino; Pelosi, Giuseppe; Albini, Adriana; Lavitrano, Marialuisa; Grassilli, Emanuela; Cerrito, Maria Grazia
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy 1-gen-2018 Albini, A.; Bruno, A.; Noonan, D. M.; Mortara, L.